Search
Enanta Pharmaceuticals Inc
ENTAAdd to Watchlist
12.660USD
+0.020+0.16%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
367.91MMarket Cap
LossP/E TTM
Financial Health
Currency: USD Updated: 2026-06-18 The current financial score of Enanta Pharmaceuticals Inc is 7.73, ranking 102 out of 157 in the Pharmaceuticals industry. Its financial status is weak, and its operating efficiency is high. Its latest quarterly revenue reached 17.16M, representing a year-over-year increase of 14.96%, while its net profit experienced a year-over-year increase of 42.19%.
Financials
5.21
Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.
Quality of Earnings
7.31
Total revenue
Operating profit
Total assets
SG&A
Relevant data have not been disclosed by the company yet.
Operational Efficiency
10.00
Cash flow from operating activities
Income after tax
Relevant data have not been disclosed by the company yet.
Growth Potential
8.68
Cash flow from operating activities
Total revenue
Relevant data have not been disclosed by the company yet.
Shareholder Returns
7.45
Free cash flow
Relevant data have not been disclosed by the company yet.
